Colorectal Cancer Market - Forecast(2019 - 2024)

Report Code: HCR 0127 Report Format: PDF + Excel Database

Colorectal Cancer Market Outlook:

Globally, colorectal cancer is the third most common cancer, and around 1.8 million new incidences came to the forefront in 2018.[1] Extensive unhealthy lifestyle, aging, higher intake of fatty foods, alcohol consumption, and others collectively contribute to the increasing colorectal cancer cases worldwide. The abnormal growth of cells in the colon and rectal spreads gradually to nearby periphery and affects normal functioning, causing unhealthy bowels, constipation, blood in feces, and other disorders. The treatment procedures include chemotherapy, immunotherapy, radiation therapy, surgical removal of cancerous outgrowth, and ablation. Diagnosis, drugs, and medication for the colorectal cancer is experiencing an uplift in the recent times owing to the high life risk. According to IndustryARC’s report, colorectal cancer treatment market value attained $9.58 billion as of 2018. The increasing advent of screening test and the possibility of reducing life risks is one of the major boosts to the global colorectal cancer treatment demand. As per the above mentioned expertise, the global colorectal cancer market will grow at a normal compound annual growth rate (CAGR) of 2.60% during the forecast period of 2019-2025.

Colorectal Cancer Market Overview:

Colorectal cancer has the second leading mortality rate in the U.S.[2] and North America is the leading global colorectal market with a regional share of 28% as of 2018 followed by Japan and Germany. Growing population and increasing obesity pose serious risks of colorectal cancer boosting the diagnostic centers in this region. Colorectal cancer starts by an ingrowth structure –polyps- in the inner side of colon or rectum. Over time polyps can develop into cancer and its surgical removal can cure colorectal cancer. Moreover, long term inflammatory bowel disease or Crohns disease might lead to colorectal cancer worsening the inflammation. CT colonoscopy diagnoses the severity of the condition and certain non-steroidal anti-inflammatory drugs are recommended to ease the risk. As per the aforementioned report, the application CAGR in diagnostic imaging centers will grow at 4.10% through to 2025.

Colorectal Cancer Market Growth Drivers:

·       Increasing incidences of colorectal cancer is compelling people to accept preventive measures such as healthy diet plan and regular exercise, and proper treatments to reduce the risk of cancer deaths. Social media is playing its part too.

·         Growing awareness about colorectal cancer through government collaboration and measures have subsequently hiked up regular screening schedules and CT colonography in developing countries, resultantly, boosting the global colorectal cancer treatment market.

Colorectal Cancer Market Challenges:

The drawbacks of colorectal cancer treatment results from the side-effects on different areas of the body. Cancer surgery induces pain, constipation, and diarrhea, whereas colostomy leads to severe irritation around the diverted opening. Radiation therapy affects regular lifestyle and includes post-treatment symptoms such as blockage of bowel movement, fatigue, skin irritation, and others. Chemotherapy is usually associated with many adverse effects on body such as nausea, hair loss, peripheral neuropathy, and many others. Meeting up these challenges via palliative treatments effectively reduces the side-effects of colon cancer treatments.

Colorectal Cancer Market Key players:

The leading market companies include F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Taiho Pharmaceutical, Eli Lilly and Company, Pfizer, Inc., Abbott Diagnostics, Quest Diagnostics, Taiwan Liposome Company Ltd., and others.

F. Hoffmann-La Roche Ltd. is a Swiss multinational company offering a wide range of drugs and diagnostic solutions for cancer and transplantation. They manufacture drugs for various chronic diseases and cancer treatment products which include Avastin, Herceptin, and MabThera. They also produce several diagnostic devices, test systems, and kits.

Colorectal Cancer Market Trends:

·         Proton beam therapy:

Proton beam therapy is an advanced treatment procedure which utilizes high energy protons radiation to treat cancer. It is a painless medical approach suitable for targeting cancers and tumors in sensitive and complex body parts where conventional treatments could damage peripheral nerves and cells.

·         TATME surgery:

Surgical treatment of colorectal cancer has been challenging since its beginning. With minimally invasive transanal total mesorectal excision (TATME) surgery, dissecting of pelvic area is easily accomplished without any complications and inconvenient pot-surgical experience of the patient. TATME surgery offers a new platform for medical execution of risk-free colorectal surgery in the modern times. This will disrupt the market in the upcoming years and be a primary trend adopted by key market players.

Colorectal Cancer Market Research Scopes:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the colorectal cancer market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of colorectal cancer in colorectal cancer market, and their specific applications in different areas.

Colorectal Cancer Market: Industry Coverage:

Global colorectal cancer market can be bifurcated into segments such as testing and diagnosis and therapies and drugs. On the basis of testing and diagnosis categorization includes macroscopy, microscopy, immunochemistry, staging, and tumor building. Based on therapies and drugs, this market can be divided into surgery, chemotherapy, radiation, therapy, immunotherapy, and others.

The colorectal cancer market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia


Reference:


[1] https://www.wcrf.org/dietandcancer/cancer-trends/colorectal-cancer-statistics

[2] https://fightcolorectalcancer.org/prevent/about-colorectal-cancer/facts-stats/

1. Colorectal Cancer Market - Overview
1.1. Definitions and Scope
2. Colorectal Cancer Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Colorectal Cancer Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Colorectal Cancer Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Colorectal Cancer Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Colorectal Cancer Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Colorectal Cancer Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Colorectal Cancer Market – By Testing & Diagnosis (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Macroscopy
8.3.2. Microscopy
8.3.3. Immunochemistry
8.3.4. Staging
8.3.5. Tumor Budding
9. Colorectal Cancer Market – By Therapies & Drugs (Market Size -$Million / $Billion)
9.1. Surgery
9.2. Chemotherapy
9.2.1. Antimetabolites
9.2.1.1. Fluorouracil (Adrucil)
9.2.1.2. Capecitabine (Xeloda)
9.2.2. Alkylating Agent - Oxaliplatin (Eloxatin)
9.2.3. Others 
9.3. Radiation Therapy
9.4. Immunotherapy
9.4.1. Monoclonal antibodies
9.4.1.1. Bevacizumab (Avastin)
9.4.1.2. Cetuximab (Erbitux) 
9.4.1.3. Panitumumab (Vectibix)
9.4.2. Others
9.5. Others
10. Colorectal Cancer - By Geography (Market Size -$Million / $Billion)
10.1. Colorectal Cancer Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Colorectal Cancer - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Colorectal Cancer - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Colorectal Cancer – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Colorectal Cancer Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Colorectal Cancer Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Colorectal Cancer Market – Key Company List by Country Premium
14. Colorectal Cancer Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. HOFFMANN LA ROCHE
14.3. DEBIOPHARM GROUP
14.4. MERCK KGAA 314
14.5. VACCINOGEN BD
14.6. Aeterna Zentaris
14.7. Keryx 326
14.8. Spectrum Pharmaceuticals, Inc
14.9. MOLOGEN AG Company
14.10. AMGEN
14.11. Bayer HealthCare
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Colorectal Cancer Market - Appendix
15.1. Abbreviations
15.2. Sources
16. Colorectal Cancer Market - Methodology
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables

Table 1: Colorectal Cancer Market Overview 2019-2024
Table 2: Colorectal Cancer Market Leader Analysis 2018-2019 (US$)
Table 3: Colorectal Cancer MarketProduct Analysis 2018-2019 (US$)
Table 4: Colorectal Cancer MarketEnd User Analysis 2018-2019 (US$)
Table 5: Colorectal Cancer MarketPatent Analysis 2013-2018* (US$)
Table 6: Colorectal Cancer MarketFinancial Analysis 2018-2019 (US$)
Table 7: Colorectal Cancer Market Driver Analysis 2018-2019 (US$)
Table 8: Colorectal Cancer MarketChallenges Analysis 2018-2019 (US$)
Table 9: Colorectal Cancer MarketConstraint Analysis 2018-2019 (US$)
Table 10: Colorectal Cancer Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Colorectal Cancer Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Colorectal Cancer Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Colorectal Cancer Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Colorectal Cancer Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Colorectal Cancer MarketValue Chain Analysis 2018-2019 (US$)
Table 16: Colorectal Cancer MarketPricing Analysis 2019-2024 (US$)
Table 17: Colorectal Cancer MarketOpportunities Analysis 2019-2024 (US$)
Table 18: Colorectal Cancer MarketProduct Life Cycle Analysis 2019-2024 (US$)
Table 19: Colorectal Cancer MarketSupplier Analysis 2018-2019 (US$)
Table 20: Colorectal Cancer MarketDistributor Analysis 2018-2019 (US$)
Table 21: Colorectal Cancer Market Trend Analysis 2018-2019 (US$)
Table 22: Colorectal Cancer Market Size 2018 (US$)
Table 23: Colorectal Cancer Market Forecast Analysis 2019-2024 (US$)
Table 24: Colorectal Cancer Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 26: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Macroscopy , 2019-2024 ($)
Table 27: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Microscopy , 2019-2024 ($)
Table 28: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Immunochemistry , 2019-2024 ($)
Table 29: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Staging , 2019-2024 ($)
Table 30: Colorectal Cancer MarketBy Testing & Diagnosis , Revenue & Volume,By Tumor Budding. , 2019-2024 ($)
Table 31: Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 32: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Surgery , 2019-2024 ($)
Table 33: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Chemotherapy , 2019-2024 ($)
Table 34: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Antimetabolites , 2019-2024 ($)
Table 35: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Radiation Therapy , 2019-2024 ($)
Table 36: Colorectal Cancer MarketBy Therapies & Drugs, Revenue & Volume,By Immunotherapy , 2019-2024 ($)
Table 37: North America Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 38: North America Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 39: South america Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 40: South america Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 41: Europe Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 42: Europe Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 43: APAC Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 44: APAC Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 45: Middle East & Africa Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 46: Middle East & Africa Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 47: Russia Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 48: Russia Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 49: Israel Colorectal Cancer Market, Revenue & Volume,By Testing & Diagnosis , 2019-2024 ($)
Table 50: Israel Colorectal Cancer Market, Revenue & Volume,By Therapies & Drugs, 2019-2024 ($)
Table 51: Top Companies 2018 (US$)Colorectal Cancer Market, Revenue & Volume,,
Table 52: Product Launch 2018-2019Colorectal Cancer Market, Revenue & Volume,,
Table 53: Mergers & Acquistions 2018-2019Colorectal Cancer Market, Revenue & Volume,,

List of Figures

Figure 1: Overview of Colorectal Cancer Market 2019-2024
Figure 2: Market Share Analysis for Colorectal Cancer Market 2018 (US$)
Figure 3: Product Comparison in Colorectal Cancer Market 2018-2019 (US$)
Figure 4: End User Profile for Colorectal Cancer Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Colorectal Cancer Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Colorectal Cancer Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Colorectal Cancer Market 2018-2019
Figure 8: Ecosystem Analysis in Colorectal Cancer Market2018
Figure 9: Average Selling Price in Colorectal Cancer Market 2019-2024
Figure 10: Top Opportunites in Colorectal Cancer Market 2018-2019
Figure 11: Market Life Cycle Analysis in Colorectal Cancer Market
Figure 12: GlobalBy Testing & Diagnosis Colorectal Cancer Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Therapies & DrugsColorectal Cancer Market Revenue, 2019-2024 ($)
Figure 14: Global Colorectal Cancer Market - By Geography
Figure 15: Global Colorectal Cancer Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Colorectal Cancer Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 18: US Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Colorectal Cancer MarketSouth America 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Colorectal Cancer MarketCosta Rica 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 93: China Colorectal Cancer MarketValue & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Colorectal Cancer MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Colorectal Cancer MarketTaiwan 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Colorectal Cancer MarketMalaysia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Colorectal Cancer MarketHong Kong 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Colorectal Cancer MarketMiddle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Colorectal Cancer MarketRussia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Colorectal Cancer Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Colorectal Cancer Market
Figure 131: Developments, 2018-2019*Colorectal Cancer Market
Figure 132: Company 1 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Colorectal Cancer Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Colorectal Cancer Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Colorectal Cancer Market Net Sales Share, By Geography, 2018 (%)